Health Politics Country 2025-12-26T19:12:38+00:00

HIV Crisis in Mexico

Mexico faces a rising HIV mortality rate due to diagnostic delays and limited prevention. Understanding risk factors, interventions, and strategies is crucial for effective action.


Health officials in Mexico report that interruptions in antiretroviral therapy (ART) and the decline of community services are raising the risk of virologic failure and hospitalizations due to advanced disease. Studies show that between 2014 and 2022, deaths attributed to advanced HIV exceeded 50 %, reversing a decade of progress. Late diagnosis and insufficient combined prevention reflect systemic failures in primary and hospital care. Most deaths occur among young people with low education and limited social security, indicating structural inequities. The report calls for systematic integration of testing, immediate ART initiation, and active provision of pre‑exposure prophylaxis (PrEP) to reduce mortality.